Tag: Sputnik V

Sputnik-V
Russian Vaccine 'Sputnik V' Found Safe In Early Human Trials

London: A Russian Covid-19 vaccine has shown no serious side effects and elicited an immune response in early human trials, said a study published in The Lancet on Friday. Russia last month registered the “Sputnik V”, becoming the first country to approve a Covid-19 vaccine. However, the country faced criticism for approving a vaccine before […]

  • Monday, 12 April 2021
COVID- 19 Vaccine
Russia To Supply 100 Million Doses Of Sputnik V Vaccine To Dr Reddy's

New Delhi: The Russian Direct Investment Fund (RDIF) and Dr Reddy’s Laboratories Limited, a global pharmaceutical company headquartered in India, have agreed to cooperate on clinical trials and distribution of Sputnik V Covid-19 vaccine in India, Russia’s sovereign wealth fund revealed in a statement on Wednesday. Sputnik V, an adenovirus vector-based vaccine, was developed by the […]

  • Monday, 12 April 2021
Russia COVID-19 Vaccine
After Sputnik V, Russia Approves Another Covid-19 Vaccine: Putin

Moscow: Russian President Vladimir Putin on Wednesday announced that the country has registered the second Covid-19 vaccine, according to media reports. Russia became the first country to give regulatory approval to a Covid-19 vaccine in August when Sputnik V was officially registered ahead of large-scale clinical trial, drawing criticism from some quarters in the scientific […]

  • Sunday, 11 April 2021
vaccc
Sputnik V Covid-19 Vaccine Gets Nod For Clinical Trials In India

New Delhi: The Drug Controller General of India (DCGI) has granted approval to Dr Reddy’s, a global pharmaceutical company headquartered in India, to conduct phase 2 and 3 clinical human trials of the Sputnik V, a Covid-19 vaccine made by Russia. On September 16, the Russian Direct Investment Fund (RDIF) and Dr Reddy’s Laboratories Limited […]

  • Sunday, 11 April 2021
Sputnik V
COVID Vaccine: Russia Seeks Sputnik V's Speedy Registration, Prequalification From WHO

New Delhi: The Russian Direct Investment Fund, the country’s sovereign wealth fund, has submitted applications to the World Health Organisation (WHO) for accelerated registration and prequalification of Sputnik V, the world’s first registered vaccine against the coronavirus. Russia has become one of the first countries to apply to WHO for prequalification of its vaccine against […]

  • Saturday, 10 April 2021
Sputnik-V-vaccine
Covid Vax: Infections Reported Among Sputnik V Trial Volunteers

Moscow: There have been instances of infection among volunteers of Sputnik V trials, the world’s first registered vaccine against Covid-19 virus, according to a top official of the developer of the Russian vaccine, said a media report. This is the reason why the developer of the vaccine, the Gamaleya National Research Center for Epidemiology and […]

  • Saturday, 10 April 2021
Sputnik V
Sputnik V Vaccine 92 Per Cent 'Effective' Against Coronavirus, Claims Russia

Moscow: Russia’s Sputnik V vaccine has shown 92 per cent efficacy in preventing COVID-19, according to interim trial results announced by the country’s health ministry on Wednesday. The announcement follows results unveiled earlier this week by vaccine developers Pfizer and BioNTech, who said their vaccine was more than 90 per cent effective at preventing COVID-19. […]

  • Friday, 09 April 2021
Sputnik V COVID-19 Vaccine Found To Be 95% Effective In Phase 3 Clinical Trials
Sputnik V COVID-19 Vaccine Found To Be 95% Effective In Phase 3 Clinical Trials

Moscow: Russia’s Sputnik V vaccine has been found to be more than 95 per cent effective against Covid-19 in the second interim analysis of Phase 3 clinical trial data, its developers said on Tuesday. The analysis was based on data from volunteers obtained 42 days after the first dose — which corresponds with 21 days […]

  • Friday, 09 April 2021
Sputnik V Working To Take AstraZeneca Vaccine Efficacy To Over 90%
Sputnik V Working To Take AstraZeneca Vaccine Efficacy To Over 90%

New Delhi: With the Drug Controller General of India (DCGI) approving Serum Institute of India’s ‘Covishield’ vaccine and Bharat Biotech’s ‘Covaxin’ for emergency use, paving way for their roll-out and administration to millions, Russian Sputnik V vaccine makers have said that they are working with AstraZeneca (AZ) to take the efficacy of AZ vaccine to […]

  • Wednesday, 07 April 2021
Sputnik V Could Be India's 3rd COVID Vaccine: Experts
Sputnik V Could Be India's 3rd COVID Vaccine: Experts

New Delhi: To cater to the vaccination process of the world’s largest democracy, it would be pertinent to bring in safer and more effective vaccines from other countries. However, on February 24, India’s drug authority had asked Dr Reddy’s, the Indian pharmaceutical company facilitating the trials in the country, to supply data on immunogenicity for […]

  • Sunday, 04 April 2021
No Sputnik V Approval Yet, SEC Asks Dr Reddy's For More Data On Russian Vaccine
No Sputnik V Approval Yet, SEC Asks Dr Reddy's For More Data On Russian Vaccine

New Delhi: The Subject Expert Committee (SEC) of the Indian drug regulator, tasked with vetting Covid-19 vaccine proposals, sought additional data on Russian Covid-19 vaccine ‘Sputnik V’, while deciding on its emergency use authorisation, a senior government official said on Thursday. In September 2020, Dr. Reddy’s had partnered with the Russian Direct Investment Fund (RDIF) […]

  • Friday, 02 April 2021
AstraZeneca
AstraZeneca Will Test Sputnik V Component In Clinical Trials Of Its Own Vaccine

New Delhi: After Sputnik V vaccines clinical trial’s preliminary results showed its efficacy at above 90 percent, the Russian Direct Investment Fund and Gamaleya Institute offered AstraZeneca the use of one of its two components in their own clinical trials. AstraZeneca accepted the proposal and will begin clinical trials of its vaccine in combination with […]

  • Monday, 01 March 2021
COVID-19 Vaccine: India To Produce 300mn Doses Of Sputnik V In 2021
COVID-19 Vaccine: India To Produce 300mn Doses Of Sputnik V In 2021

Moscow: India will produce about 300 million doses of the Russian Sputnik V COVID-19 vaccine in 2021, the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in an interview with a TV channel. “In India, we have agreements with four large manufacturers. …India will produce about 300 million doses or more of […]

  • Monday, 01 March 2021
scrollToTop